
NTrans Technologies
@ntranstech
Developing a treatment for inherited muscular disease. Stem cell transduction.
ID: 3130781801
http://www.ntranstechnologies.com 31-03-2015 16:19:50
120 Tweet
104 Followers
138 Following

Vanochtend interessante meeting Utrecht Science Park CvT programma Kansen voor West #Efro-subsidie met presentaties van projecten NTrans Technologies, #3Rtoxflow en #Neoroshirt (#Elitac)


Top #CRISPR Startup Companies Changing the Future of #Biotech and #Medicine hubs.ly/H0jwR_X0 Mammoth Biosciences eGenesis Viridos - formerly Synthetic Genomics PLANTeDIT NTrans Technologies Ligandal Caribou Biosciences Editas Medicine @intelliatweets Pairwise CRISPR Therapeutics Inari @ExonicsTx Verve Therapeutics Casebia Therapeutics






Nice article about NTrans Technologies , thanks BCF Career ! bcfcareer.nl/bcf-scale-up-a…

Horizon 2020 Utrecht University Université de Montpellier UMC Utrecht TU Eindhoven @UnivNantes Universität Ulm @nuigalway NUI Galway Medicine @NUIGalwayPress Inserm AO Foundation @AOSpineEMEA @SHUPressOffice Sheffield Hallam University NTrans Technologies @Catalyze_biomed The University of Hong Kong PharmaLex University of Miami ReumaNederland

Many thanks to the @ntrans team, the EU_#horizon2020 and EU Research Results teams for completing our H2020 project in these challenging times! Stay safe and healthy ! lnkd.in/dY4S5BM


Our partner NTrans Technologies in Utrecht/ Leiden is recruting for a project on gene editing therapies - a research scientist - a research technician NTrans Technologies Marco de Boer ntranstechnologies.com/careers/




We were extremly happy to meet with Tajbakhsh lab Graziella Messina's Lab Niels Geijsen and Marco de Boer from NTrans Technologies to discuss new insights and pool our ressources in favor of therapies for NMD, in the warm-welcoming Chateau du Mée 🏰 MuscleDare...Just be aware!

Thank you everyone for a fun day and great science! Tajbakhsh lab Graziella Messina's Lab Niels Geijsen Marco de Boer NTrans Technologies @IMRB_Mondor UPEC Inserm AFM-Téléthon


Gen-therapie tegen ziekte van #Duchenne Hoe een biotechbedrijf en het LUMC elkaar aantrekken. In het LUMC is Annemieke Aartsma-Rus een van de wetenschappers die strijden tegen deze ellendige ziekte. NTrans Technologies AnnemiekeAartsma-Rus LUMC Leiden

